Related Experiment Video
Updated: Jan 19, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels
Maria Laura Canale1, Irma Bisceglia2, Chiara Lestuzzi3
1Division of Cardiology, Azienda USL Toscana Nord-Ovest, Ospedale Versilia, Lido di Camaiore, Italy marialaura.canale@uslnordovest.toscana.it.
Abstract:
Cancer patients are at risk for both venous and arterial thrombotic events. Accumulating evidence suggests a link between cancer and arterial thrombosis events. The pathophysiology of arterial thrombosis in cancer is complex and multifactorial. The risk of arterial thrombosis in cancer patients relies on individual risk factors, on cancer-related hypercoagulability, on anticancer drugs and radiotherapy often via a common underlying mechanism of endothelial dysfunction. This review describes the mechanisms involved in the development of arterial thrombotic events and their clinical manifestations. Furthermore, it provides an overview on therapeutic agents associated with arterial thrombosis.
Related Concept Videos
07:26Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
04:40Venous Thrombosis Assay in a Mouse Model of Cancer
03:57Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
08:39Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury
10:37Ferric Chloride-induced Murine Thrombosis Models
14:52Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy

